The efficacy of low molecular weight heparin is reduced in COVID-19. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3233/ch-221635
PubMed Identifier: 36442189
Publication URI: http://europepmc.org/abstract/MED/36442189
Type: Journal Article/Review
Volume: 84
Parent Publication: Clinical hemorheology and microcirculation
Issue: 3
ISSN: 1386-0291